Evaluation and performance of desorption electrospray ionization using a triple quadrupole mass spectrometer for quantitation of pharmaceuticals in plasma.
about
Direct Mass Spectrometry Analysis of Untreated Samples of Ultralow Amounts Using Extraction Nano-Electrospray.Critical topics in ensuring data quality in bioanalytical LC-MS method development.Bioanalytical solutions to acetonitrile shortages.Development of miniature mass spectrometry systems for bioanalysis outside the conventional laboratories.The development and assessment of high-throughput mass spectrometry-based methods for the quantification of a nanoparticle drug delivery agent in cellular lysate.Ambient ionization MS for bioanalysis: recent developments and challenges.Personalized monitoring of therapeutic salicylic acid in dried blood spots using a three-layer setup and desorption electrospray ionization mass spectrometry.Development and validation of a DESI-HRMS/MS method for the fast profiling of esomeprazole and its metabolites in rat plasma: a pharmacokinetic study.The quantitative surface analysis of an antioxidant additive in a lubricant oil matrix by desorption electrospray ionization mass spectrometry.Ammonium Bicarbonate Addition Improves the Detection of Proteins by Desorption Electrospray Ionization Mass Spectrometry.Ambient desorption ionization mass spectrometry (DART, DESI) and its bioanalytical applications
P2860
Q33460204-9C65A7C2-56F9-49F6-BE47-0F8D03913DD0Q33748874-81A1175E-B636-47E9-B7C1-8ECDD7276B1DQ33748897-85D459C9-A0D0-49D3-BC28-084418757ED6Q34072869-47DC4AA6-A7D3-4AD1-9DE7-020B17C9FCE1Q35419675-1723C69E-6978-4E8F-8B9F-2F9370209DE8Q38571072-5FE7A3DC-61A5-4997-8CD0-56C2309187F0Q38985344-AE6798DB-A8EA-493B-AB54-A108B0241F12Q41002035-8A659790-3115-40F8-BFEB-C3D501F385EEQ42912417-8DE47BB2-06F3-4BBF-AA1F-DA967B10D2BBQ51094859-BD5AC689-52B1-4F97-9F2D-F13B8B584814Q56866376-6FA06632-19A2-430F-969B-963564FC5966
P2860
Evaluation and performance of desorption electrospray ionization using a triple quadrupole mass spectrometer for quantitation of pharmaceuticals in plasma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Evaluation and performance of ...... of pharmaceuticals in plasma.
@en
Evaluation and performance of ...... of pharmaceuticals in plasma.
@nl
type
label
Evaluation and performance of ...... of pharmaceuticals in plasma.
@en
Evaluation and performance of ...... of pharmaceuticals in plasma.
@nl
prefLabel
Evaluation and performance of ...... of pharmaceuticals in plasma.
@en
Evaluation and performance of ...... of pharmaceuticals in plasma.
@nl
P2860
P356
P1476
Evaluation and performance of ...... of pharmaceuticals in plasma.
@en
P2093
Joseph H Kennedy
Justin M Wiseman
P2860
P304
P356
10.1002/RCM.4390
P577
2010-02-01T00:00:00Z